CPHI Webinar Series

Market Outlook – The Biggest Pharma Trends of 2024

12th December, 2023
4pm CET / 10am EST
What will this webinar address?

The pharmaceutical industry is on the cusp of significant transformation as we move into 2024. From personalized medicines and AI-driven drug development to the growing demand for biologics, and the sophisticated technologies required to manufacture these products at scale – the industry landscape is shifting.

As always, innovation and development present the industry with fresh opportunities for growth. This webinar is designed to offer a glimpse into the trends you need to know about, helping you to navigate the evolving market and contribute to the future of healthcare.

Find out what lies in store for pharma in the coming year, by tuning into our final webinar of 2023!
In just 60 minutes, you’ll hear from expert speakers on:

  • Key trend predictions for 2024 – what’s new?
  • The Emerging Role of the Microbiome in Future Therapies
  • Leveraging AI for Advanced Patient Stratification in Microbiome Studies
  • How is the industry embracing digital technologies?
  • Digital health use-cases along the pharma value chain

Christian Roghi
Director of Microbiome Solutions - Partnerships and Ecosystem
Eagle Genomics

Christian was formerly Deputy Director for the Food Safety Centre in Norwich, UK, before becoming Head of Business Development for the Institute of Food Research and for the Quadram Institute, a world-leading institute creating new interfaces between food science, gut biology, and human health. Subsequently, Christian joined the executive team at Scottish biopharma company EnteroBiotix to help it expand within the rapidly developing area of gut microbiome therapeutics. Most recently, Christian was Director of Strategic Alliances at CosmosID (USA), a contract research organization focused on next generation sequencing and bioinformatics.

Tobias Silberzahn
McKinsey & Company, Inc.

Tobias is a Partner in McKinsey’s Berlin office, actively contributing to both the Healthcare Practice and the Innovation Practice. With a tenure spanning 14 years at McKinsey, he has dedicated his expertise to serving digital health scale-ups, established healthcare companies, and ministries of health. Tobias leads the global Health Tech Network at McKinsey, overseeing a vibrant community comprising over 1800 digital health CEOs, 300 investors, and 400 corporates.

Johannes Galatsanos
MIT Sloan Fellow
MIT Sloan School of Management

Johannes is currently an MIT Sloan Fellow specializing in AI and Quantum Computation. Concurrently, he is pursuing postgraduate studies in Artificial Intelligence at the University of Oxford. In addition to his academic pursuits, Johannes serves as an Instructor in AI at the Commercial School Zug, Switzerland.
In his previous role, Johannes played a pivotal role as the Head of Data for the Novartis Lean Digital Core Transformation. His responsibilities included ensuring that all ERP data was generated in a FAIR (Findable, Accessible, Interoperable, and Reusable) manner and maintained high quality directly at the source. This comprehensive approach spanned the entire enterprise, facilitating analytics, data science, and AI initiatives.

Market Outlook – The Biggest Pharma Trends of 2024
  • 12th December, 2023
  • 4pm CET / 10am EST
  • 60 minutes
  • Free
CPHI Newsletter

Get the latest from CPHI in your inbox every week.

You understand that your information will be used in accordance with our Privacy Policy, and that you may withdraw your permission to receive any of our communications at any time by clicking on the Unsubscribe link in the Newsletters or opting out on our unsubscribe page page.